Key Highlights
- William McKinney appointed as Chief Executive Officer and Board member of Eleanor Health, effective January 9, 2024.
- McKinney brings extensive experience from Sevita, Fresenius Medical Care, and other healthcare leadership roles, emphasizing value-based care and integrated health solutions.
- His focus on solving complex healthcare problems, particularly in addiction treatment, aligns with Eleanor’s mission of comprehensive, whole-person care.
Source: Business Wire
Notable Quotes
- “My passion in healthcare is trying to solve the hard problems, and there aren’t many things more challenging than addiction treatment.” – William McKinney, CEO at Eleanor
- “William has a proven track record of delivering mission and margin, at scale.” – David Whelan, Board Chair at Eleanor Health
- “We are thrilled to have what we think is a world-class leader like William who has both vision and execution-orientation at the helm.” – Chris Bischoff, Managing Director at General Catalyst
SoH's Take
William McKinney’s appointment as CEO of Eleanor Health is a strategic move that underscores the company’s commitment to advancing in the field of addiction and mental health care. McKinney’s background in value-based contracting and care delivery, particularly for complex populations, is critical in this era where healthcare is increasingly focusing on holistic and sustainable treatment approaches. His vision aligns seamlessly with Eleanor Health’s innovative approach, which combines physical, mental, and social well-being in treatment. This transition is not just a leadership change but a reinforcement of Eleanor’s pioneering stance in the healthcare industry, especially in tackling the intricate challenges of addiction treatment. The emphasis on value-based models and data-driven strategies under McKinney’s leadership is poised to further propel Eleanor Health’s mission and expand its impact on individuals and communities grappling with addiction and mental health issues.
Related

Eleanor Health Secures $30 Million Series D to Scale Addiction Treatment Model
Key Highlights Eleanor Health raises $30 million in Series D financing led by General Catalyst. Funds will scale Eleanor’s whole-person care model for substance use disorder. Innovative value-based payment structures improving quality and reducing costs. Eleanor’s care model includes MAT, psychiatry, therapy, and peer recovery coaching. Source: Business Wire Notable…

#88 – Corbin Petro, CEO & Co-Founder of Eleanor Health
Listen Episode Details Our guest: Corbin Petro, CEO & Co-Founder of Eleanor Health. "Eleanor Health's mission is to help people affected by addiction live amazing lives. They treat addiction like a chronic illness, and their evidence-based treatment model focuses on clinical and non-clinical factors, including medication, therapy, counseling, and meaningful connection…

UHealth and Aidoc Revolutionize Healthcare with AI-Powered Diagnostic Support
Key Highlights UHealth integrates Aidoc's AI for early detection and improved care coordination in patient diagnosis.Aidoc’s 13 FDA-cleared algorithms enhance efficiency in identifying acute abnormalities in patient scans.Real-time insights at the point of care with POC-AID initiative, transforming patient and healthcare provider experiences.Source: PR Newswire Notable Quotes "By combining our physician expertise with Aidoc's AI…